The Department of Health and Human Services and the Steven and Alexandra Cohen Foundation Oct. 10 announced the LymeX Innovation Accelerator, a $25 million, public-private partnership to expedite progress and strategically advance solutions to Lyme and other tickborne diseases.

The initiative will serve as a direct collaboration between Lyme patients, patient advocates and diverse stakeholders across academia, nonprofits, industry and government.

LymeX will use HHS’ Health+ model, while promoting education and awareness through “open innovation” to raise awareness about risk and prevention. It will also pursue and incentivize next-generation diagnostics via a series of multi-million-dollar grand prize challenges.

Related News Articles

Headline
The Cell and Gene Therapy Access Model, which seeks to increase access to treatments for Medicaid enrollees with rare and severe diseases, will initially focus…
Headline
The Centers for Disease Control and Prevention is following up on a previous alert of an outbreak of suspected fungal meningitis in Texas, which is now…
Headline
The U.S. Preventive Services Task Force yesterday released for public comment through June 5 a draft recommendation that all women get screened for breast…
Headline
In the latest podcast in AHA’s Advancing Health podcast series on leading initiatives to transform care and advance equity, leaders from Montage Health and…
Headline
The recent paralytic polio case in an unvaccinated adult in Rockland County, N.Y. and wastewater samples from communities near the patient’s residence meet the…
Headline
The Centers for Disease Control and Prevention late yesterday confirmed a case of human monkeypox in a U.S. resident who recently traveled from Nigeria to…